Skip to main content

Alector, Inc.

ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001653087

In the last 90 days, Alector, Inc. insiders filed 0 open-market purchases and 3 sales; 140 institutions reported holding it in 13F filings for Q2 2026, worth $183.4M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Alector, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of ALEC: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders149145−4
Shares58.0M59.0M+990.9K (+1.7%)
Value$360.9M$354.5M−$6.37M (−1.8%)

New holders (15)

Institutions that held Alector, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ALEC in Q2 2023
InstitutionSharesValue% of portfolio
Citadel Advisors LLC221,151$1.33M0.00%
Jane Street Group, LLC79,030$475.0K0.00%
Healthcare of Ontario Pension Plan Trust Fund74,000$444.7K0.00%
Caxton Associates LP45,540$273.7K0.04%
Occudo Quantitative Strategies LP27,326$164.2K0.02%
ExodusPoint Capital Management, LP23,366$140.0K0.00%
Y-Intercept (Hong Kong) Ltd20,637$124.0K0.01%
D. E. Shaw & Co., Inc.18,195$109.4K0.00%
Martingale Asset Management L P17,564$105.6K0.00%
State of Wyoming15,788$94.9K0.03%
Squarepoint Ops LLC13,072$78.6K0.00%
XTX Topco Ltd11,727$70.5K0.01%
Lindbrook Capital, LLC346$2.08K0.00%
Nisa Investment Advisors, LLC55$3310.00%
Allworth Financial LP42$2530.00%

Sold out (19)

Institutions that held Alector, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.